Clinical trial

Effectiveness of Dapagliflozin for Weight Loss

NCT03968224

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-08-04

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2018-08-04Date precision: day

Registry last updated2025-10-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PreDiabetesunresolved

Obesity, Morbidunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

Dapagliflozin/MetforminDRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Centro Medico Nacional Siglo XXI IMSSlead sponsor

Mapped research locations

Mexico CityMexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03968224 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.